Korean Supreme Court upholds LG Chem patent for longer-lasting OLEDs

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Korean Supreme Court upholds LG Chem patent for longer-lasting OLEDs

Sponsored by

HANOL ClassHankyul logo 2.png
LG Chem building
Shutterstock

Min Son of HANOL ClassHankyul IP & Law says the decision highlights the importance of demonstrated technical effects, claim amendments, and post-filing evidence, with potentially significant implications for the OLED industry

In a six-year patent invalidation dispute between LG Chem and SFC Co., Ltd., the South Korean Supreme Court has upheld LG Chem’s patent relating to technology for extending the lifetime of organic light-emitting diodes (OLEDs). The ruling is notable not only for its significance to a key OLED material but also for its assessment of demonstrated technical effects and post-filing evidence submitted in support of such effects.

Decision 2024Hu11125, rendered on May 14 2026, also puts LG Chem in the driving seat of a separate, ongoing infringement action against SFC, a domestic joint venture between Samsung Display and Japan’s Hodogaya Chemical Co., Ltd.

Background

In 2019, LG Chem acquired several OLED technologies, including the patent at issue, from US chemical company DuPont. The patent is directed to a deuterated anthracene-based compound useful as a blue OLED host material. Through deuteration, the compound enables a significant improvement in the lifetime of blue OLED without sacrificing other properties.

SFC and Japanese company Idemitsu Kosan, which had been monitoring the technology, promptly initiated invalidation actions before the Intellectual Property Trial and Appeal Board (IPTAB) in the same year, triggering the dispute.

First instance: LG Chem prevails before the IPTAB

Before the IPTAB, the petitioners argued that the patented invention was substantially identical to inventions disclosed in earlier-filed but later-published patent applications and therefore lacked novelty under the enlarged concept of novelty. They also argued that the invention lacked an inventive step over a combination of prior art references and that the specification failed to satisfy the support and enablement requirements.

In response, LG Chem corrected the claims to limit the claimed compound to one with at least 40% deuteration and strongly refuted the petitioners’ arguments. After three years of proceedings, the IPTAB finally ruled in favour of LG Chem in June 2022. Both petitioners appealed to the Intellectual Property High Court (the IP High Court).

Second instance: the IP High Court again rules in LG Chem’s favour

In 2023, LG Chem filed a correction trial seeking to further define the at-least 40% deuterated compound in the claims. In particular, the claims were corrected to require that the compound (of the formula below) be at least 40% deuterated, that substituents R1 to R8 be deuterium, that at least one of Ar1 to Ar4 be deuterated, and that at least one of Ar1 to Ar4 comprise at least one hydrogen.

Hanol graphic.png

The IPTAB accepted the correction in October 2023, and the IP High Court accordingly heard the case based on the corrected claims. In September 2024, the IP High Court dismissed the appeals.

When considering the enlarged concept of novelty, the IP High Court found that:

  • The earlier-filed but later-published patent applications did not disclose any anthracene-based compound as required by the corrected claims; and

  • The patented compounds exhibited a significant improvement in OLED lifetime (measured by Raw T50, the time in hours for a device to reach half its initial luminescence) – showing an average increase of more than double compared with the comparative examples – without showing degradation in other properties such as luminous efficiency, brightness, and operating voltage.

The court considered this improvement – achieved through a high level of deuteration – to constitute a new technical effect.

Accordingly, the court concluded that the patented invention was novel over the earlier-filed but later-published patent applications, as the differences in technical features could not be regarded as mere additions, deletions, or modifications of well-known conventional technologies in the specific means for solving the problem.

With regard to inventive step, the court determined that neither of the prior art references disclosed or suggested the deuteration features required by the corrected claims, let alone the improvement in OLED lifetime through deuteration. The court further found that none of the prior art references disclosed or implied the technical concept of deuterating anthracene compounds for the purpose of improving the lifetime of blue OLEDs. It therefore concluded that the patented invention could not have been easily derived from the combination of the prior art references.

Finally, the court ruled that the specification sufficiently disclosed how to synthesise and identify the claimed compounds, measure their deuteration level, and manufacture OLEDs comprising such compounds. Accordingly, a person skilled in the art could readily prepare the claimed compounds as well as predict and confirm the lifetime-improving effect based on the disclosure and common general knowledge in the art. Furthermore, the court recognised post-filing data submitted by LG Chem in support of the technical effect.

Both petitioners appealed to the Supreme Court, but Idemitsu Kosan subsequently withdrew its appeal.

Supreme Court ruling: validity upheld

The Supreme Court upheld the lower court’s decision, reaffirming the established legal principles governing the enlarged concept of novelty, inventive step, and support and enablement requirements. It found no error in the lower court’s application of those principles or its assessment of the relevant facts of the case.

Implications

This case highlights the importance of establishing a clear technical effect when defending the validity of patents in Korea. It also illustrates how carefully calibrated claim amendments can strengthen that position mid-litigation. By narrowing the claims to specific deuteration and structural features, LG Chem was able to distinguish the claimed invention from the prior art while tying those differences to a demonstrated significant improvement and a new technical effect.

The court’s consideration of post-filing data in support of the technical effect further suggests that, where properly anchored in the original disclosure, such evidence can have meaningful evidentiary value in a validity dispute.

With the question of validity now out of the way, the focus shifts to the scope of protection of the patent at hand. Following its successful defence of the patent’s validity before the IP High Court, LG Chem filed an infringement lawsuit against SFC in December 2024. The action seeks significant damages as well as injunctions against the production, sale, and importation of the allegedly infringing products, together with disposal of inventory. The infringement action is pending before the Seoul Central District Court.

Given the significant influence that a patent validity decision can have on the outcome of infringement litigation in Korea, the Supreme Court’s final ruling puts LG Chem in a favourable position in the pending infringement action. While it remains to be seen whether SFC’s products ultimately infringe the patent, the outcome of the litigation could have broader implications for the competitive landscape and patent strategies in the OLED industry, particularly given SFC’s role as a supplier of key OLED materials to LG Chem’s domestic competitor, Samsung Display.

more from across site and SHARED ros bottom lb

More from across our site

Boehringer Ingelheim has instructed a team from Kirkland, while Teva is being represented by Pinsent Masons
The Delhi High Court’s latest directions offer an opportunity to move beyond remedies against bad-faith registrations and address how suspicious applications are identified in the first place, says Fatima Baig at Lexlinc
Camilla Hamrin describes how the acquisition by Acapo Onsagers will impact Bergenstråhle’s trademark practice – and reflects on changes she has seen over 30 years in IP
On a recent trip to the French capital, we learned that the UPC is squeezing domestic litigation while firms are chasing senior talent, experimenting with AI and considering new ways of organising their practices
Daniel Law says a string of lateral hires and broader expansion plans will strengthen its position to capitalise on Brazil’s burgeoning IP and patent litigation market
Jason Raeburn’s arrival will expand the firm’s London footprint in AI, copyright and tech disputes
The firm is shaping its AI strategy around partnerships with Harvey and Legora alongside internally developed tools from its legal technology company, Eltemate
A dispute Down Under shows why trademark lawyers cannot afford to wait on the sidelines when a rival brand gathers momentum
The Third Circuit’s decision in Thomson Reuters v ROSS marks the first appellate-level decision addressing AI and fair use, prompting copyright counsel to consider arguments around potential licensing markets
Injunctions for HandsFree Labs and Align Technology come as the Court of Appeal warns that busy teams must have the staffing and resources to meet UPC deadlines
Gift this article